You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lipid-nanoparticle

Showing 1 - 25 of 3,557
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patisiran-Lipid Nanoparticle Pregnancy Surveillance Program

Recruiting
  • Hereditary Transthyretin-mediated (hATTR) Amyloidosis
  • Polyneuropathy
    • Iowa City, Iowa
    • +6 more
    Aug 11, 2022

    Advanced Solid Tumors Trial (WGI-0301)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Jul 11, 2022

    Respiratory Syncytial Virus Infection Trial in Puerto Rico, United States (RSV mRNA LNP CL-0059 Low dose, RSV mRNA LNP CL-0137

    Recruiting
    • Respiratory Syncytial Virus Infection
    • RSV mRNA LNP CL-0059 Low dose
    • +6 more
    • Hollywood, Florida
    • +4 more
    Jan 17, 2023

    Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Ovarian Cancer Trial in United States (mRNA-2416, Durvalumab)

    Terminated
    • Relapsed/Refractory Solid Tumor Malignancies or Lymphoma
    • Ovarian Cancer
    • mRNA-2416
    • Durvalumab
    • Aurora, Colorado
    • +8 more
    Jul 7, 2022

    SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2)

    Completed
    Has Results
    • SARS-CoV-2 Infection
    • COVID-19
    • BNT162b2
    • Anaheim, California
    • +20 more
    Nov 30, 2022

    COVID-19, COVID-19 Immunisation Trial in United States (mRNA-1273, mRNA-1273.351)

    Active, not recruiting
    • COVID-19
    • COVID-19 Immunisation
    • mRNA-1273
    • mRNA-1273.351
    • Decatur, Georgia
    • +3 more
    Aug 11, 2022

    COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)

    Completed
    • COVID-19
    • COVID-19 Immunisation
    • mRNA-1273
    • Decatur, Georgia
    • +2 more
    Jan 26, 2023

    COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)

    Not yet recruiting
    • COVID-19 Infection
    • COVID-19 Vaccine Adverse Reaction
    • LEM-mR203
    • Placebo
    • Seoul, Korea, Republic of
      Seoul National University Hospital Clinical Trials Center
    Sep 12, 2023

    COVID-19 Trial in United States (drug, biological, other)

    Active, not recruiting
    • COVID-19
    • Birmingham, Alabama
    • +21 more
    Feb 2, 2023

    SARS-CoV-2 Infection Trial (PTX-COVID19-B, Vaxzevria®)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • PTX-COVID19-B
    • Vaxzevria®
    • (no location specified)
    Sep 7, 2022

    Cystic Fibrosis Trial in Christchurch (ARCT-032, Placebo)

    Not yet recruiting
    • Cystic Fibrosis
    • Christchurch, New Zealand
      New Zealand Clinical Research
    Feb 3, 2023

    Epithelial Tumors, Malignant Trial in Randwick (MT-302 (A))

    Recruiting
    • Epithelial Tumors, Malignant
    • MT-302 (A)
    • Randwick, New South Wales, Australia
      Scientia Clinical Research Ltd
    Aug 1, 2023

    SARS-CoV-2 Infection Trial (PTX-COVID19-B, Comirnaty®)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • PTX-COVID19-B
    • Comirnaty®
    • (no location specified)
    Sep 7, 2022

    Solid Tumor Trial in Belgium, Netherlands (INT-1B3)

    Recruiting
    • Solid Tumor
    • Brussels, Wallonie, Belgium
    • +3 more
    Feb 4, 2022

    SARS-CoV-2 Trial in Salvador (Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine, Cohort 2 RNA VACCINE MCTI CIMATEC

    Recruiting
    • SARS-CoV-2
    • Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine
    • +3 more
    • Salvador, Bahia, Brazil
      Hospital da Bahia
    Mar 23, 2022

    SARS-CoV-2 Trial in Singapore (ARCT-021 Dose 1, ARCT-021 Dose 2, ARCT-021 Dose 3)

    Completed
    • SARS-CoV-2
    • ARCT-021 Dose 1
    • +6 more
    • Singapore, Singapore
      SingHealth Investigational Medicine Unit (IMU), Singapore Genera
    Aug 12, 2021

    COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)

    Active, not recruiting
    • COVID-19
    • SARS-CoV-2
    • QTP104 1ug
    • +2 more
    • Seoul, Korea, Republic of
    • +1 more
    May 24, 2023

    Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • quaratusugene ozeplasmid
    • atezolizumab
    • (no location specified)
    Jan 19, 2023

    Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)

    Recruiting
    • Non Small Cell Lung Cancer
    • quaratusugene ozeplasmid
    • +3 more
    • Tampa, Florida
    • +2 more
    Sep 12, 2022

    Influenza Trial in Iowa City (DCVC H1 HA mRNA vaccine, Quadrivalent Recombinant Seasonal Influenza Vaccine, Sodium Chloride,

    Not yet recruiting
    • Influenza
    • DCVC H1 HA mRNA vaccine
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics - Department of Internal
    Jul 6, 2023

    COVID-19, COVID-19 Vaccine Trial (RNA MCTI CIMATEC HDT 5µg, RNA MCTI CIMATEC HDT 10µg, Covishield® - AstraZeneca)

    Not yet recruiting
    • COVID-19
    • COVID-19 Vaccine
    • RNA MCTI CIMATEC HDT 5µg
    • +3 more
    • (no location specified)
    Sep 13, 2022

    Ornithine Transcarbamylase Deficiency Trial in United States (ARCT-810, Placebo)

    Recruiting
    • Ornithine Transcarbamylase Deficiency
    • ARCT-810
    • Placebo
    • Gainesville, Florida
    • +7 more
    Jul 18, 2022

    COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)

    Not yet recruiting
    • COVID-19
    • Pfizer-BioNTech Standard dose
    • +5 more
    • Bandung, West Java, Indonesia
    • +2 more
    Nov 30, 2022

    Influenza Trial in Durham (Influenza Virus Quadrivalent Inactivated Vaccine, Sodium Chloride, 0.9%, VRC-FLUNPF099-00-VP

    Not yet recruiting
    • Influenza
    • Influenza Virus Quadrivalent Inactivated Vaccine
    • +2 more
    • Durham, North Carolina
      Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
    Feb 23, 2023

    COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

    Not yet recruiting
    • COVID-19
    • Tozinameran
    • +3 more
    • Melbourne, Victoria, Australia
      Royal Children's Hospital, Murdoch Children's Research Institute
    Sep 14, 2022